CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: ketoxime
Accession: CHEBI:24983
browse the term
Definition: Oximes of ketones R2 C=NOH (where R ≠ H).
Synonyms: related_synonym: ketoximes
chemrof_formula: CHNOR2
chemrof_smiles: [1*]/C([2*])=N/O
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions increases expression
ISO EXP
6-bromoindirubin-3'-oxime results in increased expression of and results in increased activity of ABCB1 protein 6-bromoindirubin-3'-oxime results in increased expression of ABCB1 mRNA 6-bromoindirubin-3'-oxime results in increased expression of ABCB1A mRNA; 6-bromoindirubin-3'-oxime results in increased expression of ABCB1A protein
CTD
PMID:18624906
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of ABCC2 mRNA; 6-bromoindirubin-3'-oxime results in increased expression of ABCC2 protein
CTD
PMID:18624906
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
G
Abcc4
ATP binding cassette subfamily C member 4
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of ABCC4 mRNA; 6-bromoindirubin-3'-oxime results in increased expression of ABCC4 protein
CTD
PMID:18624906
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
G
Abcg2
ATP binding cassette subfamily G member 2
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of ABCG2 mRNA; 6-bromoindirubin-3'-oxime results in increased expression of ABCG2 protein
CTD
PMID:18624906
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
6-bromoindirubin-3'-oxime binds to and results in increased activity of AHR protein
CTD
PMID:26259606
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
multiple interactions
ISO
[sorafenib co-treated with 6-bromoindirubin-3'-oxime] affects the localization of AIFM1 protein
CTD
PMID:17991738
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of ALDH1 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of ALDH1 protein]
CTD
PMID:37116855
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in decreased expression of BAX protein
CTD
PMID:37116855
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of BCL2 protein
CTD
PMID:37116855
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
G
Casp3
caspase 3
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in decreased cleavage of CASP3 protein
CTD
PMID:37116855
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp8
caspase 8
multiple interactions
ISO
6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in increased expression of CASP8 protein modified form]
CTD
PMID:28414160
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
G
Ccnd1
cyclin D1
increases expression
ISO EXP
6-bromoindirubin-3'-oxime results in increased expression of CCND1 mRNA
CTD
PMID:18624906
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
G
Cdh1
cadherin 1
multiple interactions
ISO
6-bromoindirubin-3'-oxime inhibits the reaction [Amiodarone results in increased expression of CDH1 protein]
CTD
PMID:26515726
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
G
Cdx1
caudal type homeo box 1
multiple interactions
ISO
[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of CDX1 mRNA
CTD
PMID:27693483
NCBI chr18:56,742,970...56,761,299
Ensembl chr18:56,742,984...56,761,299
G
Ctnnb1
catenin beta 1
multiple interactions decreases phosphorylation increases expression
ISO
[6-bromoindirubin-3'-oxime co-treated with DHFR mRNA] affects the expression of CTNNB1 protein; broussochalcone A inhibits the reaction [6-bromoindirubin-3'-oxime results in increased expression of CTNNB1 protein]; Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in decreased phosphorylation of CTNNB1 protein] [trametinib co-treated with 6-bromoindirubin-3'-oxime] results in decreased expression of CTNNB1 protein
CTD
PMID:18624906 PMID:19727391 PMID:26259606 PMID:31163223 PMID:37116855
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression multiple interactions
ISO
6-bromoindirubin-3'-oxime results in increased expression of CYP1A2 mRNA 6-bromoindirubin-3'-oxime results in increased expression of and results in increased activity of CYP1A2 protein
CTD
PMID:26259606
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
multiple interactions
ISO
[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] affects the expression of CYP26A1 mRNA
CTD
PMID:27693483
NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657
G
Ddx3x
DEAD-box helicase 3, X-linked
multiple interactions
ISO
6-bromoindirubin-3'-oxime promotes the reaction [Paraquat inhibits the reaction [TNFRSF10B protein binds to DDX3X protein]]; 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in decreased expression of DDX3X protein modified form]
CTD
PMID:28414160
NCBI chr X:12,152,346...12,165,983
Ensembl chr X:12,152,346...12,165,983
G
Dhfr
dihydrofolate reductase
multiple interactions
ISO
[6-bromoindirubin-3'-oxime co-treated with DHFR mRNA] affects the expression of CTNNB1 protein
CTD
PMID:19727391
NCBI chr 2:25,320,895...25,346,004
G
Diablo
diablo, IAP-binding mitochondrial protein
multiple interactions
ISO
6-bromoindirubin-3'-oxime promotes the reaction [sorafenib affects the localization of DIABLO protein]
CTD
PMID:17991738
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265
G
Gsk3a
glycogen synthase kinase 3 alpha
multiple interactions
ISO
6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in decreased expression of GSK3A protein modified form]
CTD
PMID:28414160
NCBI chr 1:89,943,669...89,953,514
Ensembl chr 1:89,943,669...89,953,593
G
Gsk3b
glycogen synthase kinase 3 beta
decreases activity increases phosphorylation multiple interactions
ISO
6-bromoindirubin-3'-oxime results in decreased activity of GSK3B protein 6-bromoindirubin-3'-oxime results in increased phosphorylation of GSK3B protein 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat inhibits the reaction [TNFRSF10B protein binds to GSK3B protein]]; 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in decreased expression of GSK3B protein modified form]; Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in increased phosphorylation of GSK3B protein] [trametinib co-treated with 6-bromoindirubin-3'-oxime] affects the phosphorylation of GSK3B protein
CTD
PMID:17329570 PMID:17991738 PMID:19727391 PMID:28414160 PMID:37116855
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
G
Hoxa1
homeobox A1
multiple interactions
ISO
[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] affects the expression of HOXA1 mRNA
CTD
PMID:27693483
NCBI chr 4:82,586,505...82,589,209
Ensembl chr 4:82,586,505...82,589,209
G
Il6
interleukin 6
multiple interactions
ISO
[6-bromoindirubin-3'-oxime co-treated with Methotrexate] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:19727391
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Itga6
integrin subunit alpha 6
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of ITGA6 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of ITGA6 protein]
CTD
PMID:37116855
NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:77,017,766...77,097,076
G
Krt17
keratin 17
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of KRT17 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of KRT17 protein]
CTD
PMID:37116855
NCBI chr10:85,679,068...85,683,792
Ensembl chr10:85,679,070...85,683,787
G
Lef1
lymphoid enhancer binding factor 1
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of LEF1 protein
CTD
PMID:17329570
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929
G
Lgr5
leucine rich repeat containing G protein coupled receptor 5
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of LGR5 mRNA
CTD
PMID:26259606
NCBI chr 7:52,973,151...53,107,964
Ensembl chr 7:52,974,332...53,108,163
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
ISO
6-bromoindirubin-3'-oxime results in decreased expression of MCL1 protein
CTD
PMID:17991738
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782
G
Mki67
marker of proliferation Ki-67
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of MKI67 protein
CTD
PMID:37116855
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
G
Nanog
Nanog homeobox
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of NANOG protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of NANOG protein]
CTD
PMID:37116855
NCBI chr 4:157,615,687...157,623,061
Ensembl chr 4:157,615,687...157,623,061
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in increased expression of PARP1 protein modified form]
CTD
PMID:28414160
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
G
Pax8
paired box 8
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of PAX8 protein
CTD
PMID:17329570
NCBI chr 3:27,584,000...27,641,094
Ensembl chr 3:27,584,002...27,640,631
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
multiple interactions
ISO
6-bromoindirubin-3'-oxime inhibits the reaction [sorafenib results in decreased expression of PMAIP1 protein]
CTD
PMID:17991738
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
G
Pou5f1
POU class 5 homeobox 1
multiple interactions
ISO
[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] results in decreased expression of POU5F1 mRNA [trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of POU5F1 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of POU5F1 protein]
CTD
PMID:27693483 PMID:37116855
NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,227,837...3,232,598
G
Sox2
SRY-box transcription factor 2
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of SOX2 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of SOX2 protein]
CTD
PMID:37116855
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:119,454,541...119,496,350
G
Tcf7
transcription factor 7
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of TCF7 protein
CTD
PMID:17329570
NCBI chr10:36,924,363...36,954,279
Ensembl chr10:36,924,363...36,954,279
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[6-bromoindirubin-3'-oxime co-treated with Methotrexate] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:19727391
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Wnt3
Wnt family member 3
multiple interactions
ISO
[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] results in decreased expression of WNT3 mRNA
CTD
PMID:27693483
NCBI chr10:89,180,224...89,224,195
Ensembl chr10:89,216,801...89,224,195
G
Slc22a6
solute carrier family 22 member 6
multiple interactions increases uptake
ISO
cefdinir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of cefdinir
CTD
PMID:16098483
NCBI chr 1:214,951,493...214,960,317
Ensembl chr 1:214,951,867...214,960,311
G
Slc22a8
solute carrier family 22 member 8
multiple interactions increases uptake
ISO
cefdinir inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] SLC22A8 protein results in increased uptake of cefdinir
CTD
PMID:16098483
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
G
Ache
acetylcholinesterase
multiple interactions
ISO
diacetylmonoxime inhibits the reaction [cyclohexyl methylphosphonofluoridate binds to and results in decreased activity of ACHE protein]; diacetylmonoxime inhibits the reaction [Paraoxon binds to and results in decreased activity of ACHE protein]; diacetylmonoxime inhibits the reaction [Sarin binds to and results in decreased activity of ACHE protein]; diacetylmonoxime inhibits the reaction [tabun results in decreased activity of ACHE protein]; diacetylmonoxime inhibits the reaction [VX-agent binds to and results in decreased activity of ACHE protein]
CTD
PMID:22960624 PMID:22975155
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
G
Acta2
actin alpha 2, smooth muscle
decreases expression affects localization
EXP ISO
diacetylmonoxime results in decreased expression of ACTA2 diacetylmonoxime affects the localization of ACTA2 protein
CTD
PMID:11591817 PMID:11868461
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
G
Bche
butyrylcholinesterase
multiple interactions
EXP
diacetylmonoxime inhibits the reaction [Dichlorvos results in decreased activity of BCHE protein]; diacetylmonoxime inhibits the reaction [Isoflurophate results in decreased activity of BCHE protein]
CTD
PMID:1276991
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
G
Casp3
caspase 3
multiple interactions
ISO
diacetylmonoxime inhibits the reaction [Demecolcine results in increased activity of CASP3 protein]
CTD
PMID:12530016
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
ISO
diacetylmonoxime results in decreased expression of CDKN1A protein
CTD
PMID:15252113
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
diacetylmonoxime results in increased expression of CDKN1B protein
CTD
PMID:15252113
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
G
Myod1
myogenic differentiation 1
decreases expression
ISO
diacetylmonoxime results in decreased expression of MYOD1 protein
CTD
PMID:15252113
NCBI chr 1:106,021,161...106,023,871
Ensembl chr 1:106,021,161...106,023,871
G
Myog
myogenin
decreases expression
ISO
diacetylmonoxime results in decreased expression of MYOG protein
CTD
PMID:15252113
NCBI chr13:48,297,476...48,300,065
Ensembl chr13:48,297,235...48,300,065
G
Tf
transferrin
decreases uptake
ISO
diacetylmonoxime results in decreased uptake of TF protein
CTD
PMID:16563724
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400
G
Actb
actin, beta
affects expression
ISO
indirubin-3'-monoxime affects the expression of ACTB protein
CTD
PMID:18958680
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
G
Ahr
aryl hydrocarbon receptor
multiple interactions affects binding
ISO
AHR protein affects the susceptibility to [indirubin-3'-monoxime results in decreased expression of CD86 protein]; AHR protein affects the susceptibility to [indirubin-3'-monoxime results in decreased expression of ITGAX protein] indirubin-3'-monoxime binds to and results in increased activity of AHR protein indirubin-3'-monoxime binds to AHR protein
CTD
PMID:15001395 PMID:21948866
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
multiple interactions increases expression
ISO
Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of ALDH1A1 protein]
CTD
PMID:21948866
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases expression
ISO
indirubin-3'-monoxime results in decreased expression of ALDH1A2 protein
CTD
PMID:21948866
NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883
G
Aqp9
aquaporin 9
multiple interactions
ISO
indirubin-3'-monoxime promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 mRNA]; indirubin-3'-monoxime promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein]
CTD
PMID:18344322
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240
G
Ar
androgen receptor
increases activity
ISO
indirubin-3'-monoxime analog results in increased activity of AR protein; indirubin-3'-monoxime results in increased activity of AR protein
CTD
PMID:21111724
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression
ISO
indirubin-3'-monoxime results in decreased expression of BAX mRNA
CTD
PMID:18958680
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2L1 mRNA
CTD
PMID:18958680
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
G
Casp8
caspase 8
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CASP8 mRNA
CTD
PMID:18958680
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
G
Cat
catalase
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CAT mRNA
CTD
PMID:18958680
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Ccl4
C-C motif chemokine ligand 4
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CCL4 mRNA
CTD
PMID:18958680
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
G
Cd40
CD40 molecule
multiple interactions decreases expression
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased expression of CD40 protein; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 protein] indirubin-3'-monoxime results in decreased expression of CD40 protein
CTD
PMID:21948866
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
G
Cd80
Cd80 molecule
increases expression multiple interactions
ISO
indirubin-3'-monoxime results in increased expression of CD80 protein [Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in increased expression of CD80 protein; indirubin-3'-monoxime promotes the reaction [Lipopolysaccharides results in increased expression of CD80 protein]
CTD
PMID:21948866
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
G
Cd86
CD86 molecule
multiple interactions decreases expression
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased expression of CD86 protein; AHR protein affects the susceptibility to [indirubin-3'-monoxime results in decreased expression of CD86 protein]; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 protein]
CTD
PMID:21948866
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
G
Cdk2
cyclin dependent kinase 2
decreases activity
ISO
indirubin-3'-monoxime results in decreased activity of CDK2 protein
CTD
PMID:12534346
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CDKN1A mRNA
CTD
PMID:18958680
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression
ISO EXP
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CYP1A1 mRNA; [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP1A1 mRNA; [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP1A1 protein indirubin-3'-monoxime results in increased expression of CYP1A1 mRNA indirubin-3'-monoxime results in increased expression of CYP1A1 protein
CTD
PMID:15001395 PMID:18958680 PMID:21948866
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Ephx2
epoxide hydrolase 2
decreases expression
ISO
indirubin-3'-monoxime results in decreased expression of EPHX2 mRNA
CTD
PMID:18958680
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
G
Gpx1
glutathione peroxidase 1
decreases expression
ISO
indirubin-3'-monoxime results in decreased expression of GPX1 mRNA
CTD
PMID:18958680
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
G
Gsk3b
glycogen synthase kinase 3 beta
decreases activity
ISO
indirubin-3'-monoxime results in decreased activity of GSK3B protein
CTD
PMID:12534346
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
indirubin-3'-monoxime results in increased expression of GSR mRNA
CTD
PMID:18958680
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HMOX1 mRNA
CTD
PMID:18958680
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Hspa2
heat shock protein family A (Hsp70) member 2
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in decreased expression of HSPA2 mRNA; [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA2 mRNA
CTD
PMID:18958680
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:100,864,553...100,867,133
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA6 mRNA
CTD
PMID:18958680
NCBI chr13:85,805,911...85,807,052
G
Hspa9
heat shock protein family A (Hsp70) member 9
multiple interactions increases expression
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA9 mRNA indirubin-3'-monoxime results in increased expression of HSPA9 mRNA
CTD
PMID:18958680
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
G
Icam1
intercellular adhesion molecule 1
multiple interactions decreases expression
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased expression of ICAM1 protein; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] indirubin-3'-monoxime results in decreased expression of ICAM1 protein
CTD
PMID:21948866
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Ido1
indoleamine 2,3-dioxygenase 1
increases expression multiple interactions
ISO
indirubin-3'-monoxime results in increased expression of IDO1 protein Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of IDO1 protein]
CTD
PMID:21948866
NCBI chr16:74,133,259...74,145,328
Ensembl chr16:74,133,259...74,145,328
G
Ido2
indoleamine 2,3-dioxygenase 2
increases expression multiple interactions
ISO
indirubin-3'-monoxime results in increased expression of IDO2 protein Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of IDO2 protein]
CTD
PMID:21948866
NCBI chr16:74,161,761...74,200,651
Ensembl chr16:74,161,774...74,200,650
G
Ifng
interferon gamma
decreases secretion
ISO
indirubin-3'-monoxime results in decreased secretion of IFNG protein
CTD
PMID:21948866
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Il10
interleukin 10
multiple interactions decreases secretion
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in increased secretion of IL10 protein; indirubin-3'-monoxime promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] indirubin-3'-monoxime results in decreased secretion of IL10 protein
CTD
PMID:21948866
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased secretion of IL1B protein; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
CTD
PMID:21948866
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il2
interleukin 2
increases secretion
ISO
indirubin-3'-monoxime results in increased secretion of IL2 protein
CTD
PMID:21948866
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
G
Il27
interleukin 27
decreases expression multiple interactions
ISO
indirubin-3'-monoxime results in decreased expression of IL27 protein Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in decreased expression of IL27 protein]
CTD
PMID:21948866
NCBI chr 1:190,603,684...190,609,292
Ensembl chr 1:190,603,522...190,609,258
G
Il6
interleukin 6
multiple interactions
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased expression of IL6 protein; [Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased secretion of IL6 protein; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:21948866
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Itgax
integrin subunit alpha X
multiple interactions decreases expression
ISO
AHR protein affects the susceptibility to [indirubin-3'-monoxime results in decreased expression of ITGAX protein]; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAX protein]
CTD
PMID:21948866
NCBI chr 1:192,140,089...192,171,151
Ensembl chr 1:192,149,905...192,171,151
G
Klk1c10
kallikrein 1-related peptidase C10
increases expression
ISO
indirubin-3'-monoxime analog results in increased expression of KLK3 mRNA; indirubin-3'-monoxime results in increased expression of KLK3 mRNA
CTD
PMID:21111724
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
G
Lck
LCK proto-oncogene, Src family tyrosine kinase
decreases activity
ISO
indirubin-3'-monoxime results in decreased activity of LCK protein
CTD
PMID:12534346
NCBI chr 5:147,172,642...147,201,267
Ensembl chr 5:147,172,642...147,201,267
G
Mt2
metallothionein 2
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MT2A mRNA
CTD
PMID:18958680
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in decreased expression of NFKBIA mRNA
CTD
PMID:18958680
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA; [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein
CTD
PMID:18958680
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
indirubin-3'-monoxime results in decreased expression of RAD23A mRNA
CTD
PMID:18958680
NCBI chr19:40,219,235...40,225,543
Ensembl chr19:40,219,636...40,225,543
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions decreases activity
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in increased activity of RELA protein indirubin-3'-monoxime results in decreased activity of RELA protein
CTD
PMID:21948866
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
G
Serpine1
serpin family E member 1
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SERPINE1 mRNA
CTD
PMID:18958680
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
G
Sgk1
serum/glucocorticoid regulated kinase 1
decreases activity
ISO
indirubin-3'-monoxime results in decreased activity of SGK1 protein
CTD
PMID:12534346
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOD2 mRNA
CTD
PMID:18958680
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
G
Tgfb2
transforming growth factor, beta 2
increases expression multiple interactions
ISO
indirubin-3'-monoxime results in increased expression of TGFB2 protein Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of TGFB2 protein]
CTD
PMID:21948866
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
G
Tgfb3
transforming growth factor, beta 3
increases expression multiple interactions
ISO
indirubin-3'-monoxime results in increased expression of TGFB3 protein Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of TGFB3 protein]
CTD
PMID:21948866
NCBI chr 6:111,435,170...111,457,646
Ensembl chr 6:111,435,170...111,456,946
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased secretion of TNF protein; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:21948866
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Ung
uracil-DNA glycosylase
increases expression
ISO
indirubin-3'-monoxime results in increased expression of UNG mRNA
CTD
PMID:18958680
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:48,145,838...48,155,257
G
Aars1
alanyl-tRNA synthetase 1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of AARS1 mRNA
CTD
PMID:37748715
NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497
G
Abcf3
ATP binding cassette subfamily F member 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ABCF3 mRNA
CTD
PMID:37748715
NCBI chr11:93,844,863...93,856,595
Ensembl chr11:93,844,363...93,856,595
G
Ace
angiotensin I converting enzyme
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ACE mRNA
CTD
PMID:37748715
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
G
Adap2
ArfGAP with dual PH domains 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADAP2 mRNA
CTD
PMID:37748715
NCBI chr10:65,635,891...65,665,019
Ensembl chr10:65,622,434...65,664,022
G
Adgra2
adhesion G protein-coupled receptor A2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRA2 mRNA
CTD
PMID:37748715
NCBI chr16:71,635,814...71,674,275
Ensembl chr16:71,636,164...71,674,154
G
Adgra3
adhesion G protein-coupled receptor A3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRA3 mRNA
CTD
PMID:37748715
NCBI chr14:65,085,418...65,188,949
Ensembl chr14:65,087,380...65,188,959
G
Adgrg1
adhesion G protein-coupled receptor G1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRG1 mRNA
CTD
PMID:37748715
NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124
G
Akirin1
akirin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AKIRIN1 mRNA
CTD
PMID:37748715
NCBI chr 5:141,274,174...141,289,617
Ensembl chr 5:141,274,175...141,289,575
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of ALDH18A1 mRNA
CTD
PMID:37748715
NCBI chr 1:249,325,082...249,357,383
Ensembl chr 1:249,325,082...249,357,383
G
Alkbh5
alkB homolog 5, RNA demethylase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ALKBH5 mRNA
CTD
PMID:37748715
NCBI chr10:45,844,411...45,865,853
Ensembl chr10:45,843,656...45,869,658
G
Apbb1ip
amyloid beta precursor protein binding family B member 1 interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of APBB1IP mRNA
CTD
PMID:37748715
NCBI chr17:89,849,474...89,941,099
Ensembl chr17:89,671,716...89,941,089
G
Apela
apelin receptor early endogenous ligand
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of APELA mRNA
CTD
PMID:37748715
NCBI chr16:29,460,855...29,469,962
Ensembl chr16:29,460,812...29,469,955
G
Arih2
ariadne RBR E3 ubiquitin protein ligase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARIH2 mRNA
CTD
PMID:37748715
NCBI chr 8:118,175,267...118,234,425
Ensembl chr 8:118,175,267...118,234,284
G
Arl14ep
ARF like GTPase 14 effector protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARL14EP mRNA
CTD
PMID:37748715
NCBI chr 3:113,896,731...113,908,994
Ensembl chr 3:113,898,076...113,908,833
G
Arnt
aryl hydrocarbon receptor nuclear translocator
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARNT mRNA
CTD
PMID:37748715
NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546
G
Arrdc4
arrestin domain containing 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARRDC4 mRNA
CTD
PMID:37748715
NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565
G
Asb8
ankyrin repeat and SOCS box-containing 8
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ASB8 mRNA
CTD
PMID:37748715
NCBI chr 7:131,140,455...131,176,648
Ensembl chr 7:131,141,406...131,150,633
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of ASNS mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of ASNS mRNA]
CTD
PMID:37748715
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
G
Ate1
arginyltransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATE1 mRNA
CTD
PMID:37748715
NCBI chr 1:194,391,843...194,514,284
Ensembl chr 1:194,391,843...194,511,348
G
Atf2
activating transcription factor 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF2 mRNA
CTD
PMID:37748715
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:79,126,705...79,202,745
G
Atf3
activating transcription factor 3
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of ATF3 mRNA
CTD
PMID:37748715
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
G
Atf4
activating transcription factor 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF4 mRNA
CTD
PMID:37748715
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
G
Atf5
activating transcription factor 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF5 mRNA
CTD
PMID:37748715
NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183
G
Atf6
activating transcription factor 6
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF6 mRNA
CTD
PMID:37748715
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
G
Aup1
AUP1, lipid droplet regulating VLDL assembly factor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AUP1 mRNA
CTD
PMID:37748715
NCBI chr 4:117,118,035...117,121,063
Ensembl chr 4:117,117,999...117,121,061
G
Avil
advillin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AVIL mRNA
CTD
PMID:37748715
NCBI chr 7:64,711,294...64,729,436
Ensembl chr 7:64,711,403...64,729,436
G
B3galnt1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of B3GALNT1 mRNA
CTD
PMID:37748715
NCBI chr 2:156,157,234...156,187,037
Ensembl chr 2:156,156,265...156,188,404
G
Bbx
BBX high mobility group box domain containing
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BBX mRNA
CTD
PMID:37748715
NCBI chr11:63,850,034...64,097,700
Ensembl chr11:63,850,018...64,093,265
G
Bglap
bone gamma-carboxyglutamate protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BGLAP mRNA
CTD
PMID:37748715
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
G
Brms1l
BRMS1 like transcriptional repressor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BRMS1L mRNA
CTD
PMID:37748715
NCBI chr 6:79,001,803...79,035,735
Ensembl chr 6:79,000,615...79,035,734
G
Calml4
calmodulin-like 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CALML4 mRNA
CTD
PMID:37748715
NCBI chr 8:72,218,870...72,230,650
Ensembl chr 8:72,218,613...72,230,650
G
Carhsp1
calcium regulated heat stable protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CARHSP1 mRNA
CTD
PMID:37748715
NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770
G
Carmil1
capping protein regulator and myosin 1 linker 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CARMIL1 mRNA
CTD
PMID:37748715
NCBI chr17:41,235,819...41,516,204
Ensembl chr17:41,236,229...41,516,221
G
Cars1
cysteinyl-tRNA synthetase 1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of CARS mRNA
CTD
PMID:37748715
NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407
G
Cbx7
chromobox 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CBX7 mRNA
CTD
PMID:37748715
NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:113,341,030...113,358,346
G
Ccnb2
cyclin B2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CCNB2 mRNA
CTD
PMID:37748715
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682
G
Cd68
Cd68 molecule
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CD68 mRNA
CTD
PMID:37748715
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CDCA3 mRNA
CTD
PMID:37748715
NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068
G
Cebpg
CCAAT/enhancer binding protein gamma
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CEBPG mRNA
CTD
PMID:37748715
NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:96,810,214...96,830,283
G
Cep170
centrosomal protein 170
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CEP170 mRNA
CTD
PMID:37748715
NCBI chr13:91,201,808...91,285,990
Ensembl chr13:91,201,808...91,285,990
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of CHAC1 mRNA]
CTD
PMID:37748715
NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361
G
Coa7
cytochrome c oxidase assembly factor 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COA7 mRNA
CTD
PMID:37748715
NCBI chr 5:128,298,084...128,308,935
Ensembl chr 5:128,298,093...128,309,664
G
Commd5
COMM domain containing 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COMMD5 mRNA
CTD
PMID:37748715
NCBI chr 7:110,502,492...110,503,916
Ensembl chr 7:110,479,403...110,505,897
G
Cox6a2
cytochrome c oxidase subunit 6A2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COX6A2 mRNA
CTD
PMID:37748715
NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716
G
Cpt1a
carnitine palmitoyltransferase 1A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CPT1A mRNA
CTD
PMID:37748715
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
G
Cryzl1
crystallin zeta like 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CRYZL1 mRNA
CTD
PMID:37748715
NCBI chr11:44,419,099...44,464,366
Ensembl chr11:44,419,103...44,463,793
G
Csf3r
colony stimulating factor 3 receptor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CSF3R mRNA
CTD
PMID:37748715
NCBI chr 5:143,583,126...143,604,382
Ensembl chr 5:143,583,213...143,602,411
G
Ctps2
CTP synthase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CTPS2 mRNA
CTD
PMID:37748715
NCBI chr X:35,277,658...35,418,505
Ensembl chr X:35,277,658...35,418,505
G
Cyb5b
cytochrome b5 type B
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine; [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980
G
Cyb5r3
cytochrome b5 reductase 3
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine; [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306
G
Dcaf15
DDB1 and CUL4 associated factor 15
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DCAF15 mRNA
CTD
PMID:37748715
NCBI chr19:40,958,693...40,966,043
Ensembl chr19:40,958,693...40,966,043
G
Ddhd2
DDHD domain containing 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDHD2 mRNA
CTD
PMID:37748715
NCBI chr16:73,022,136...73,051,746
Ensembl chr16:73,022,193...73,051,745
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of DDIT3 mRNA]
CTD
PMID:37748715
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of DDIT4 mRNA
CTD
PMID:37748715
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
G
Ddx19b
DEAD-box helicase 19B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDX19B mRNA
CTD
PMID:37748715
NCBI chr19:55,877,567...55,910,134
Ensembl chr19:55,877,567...55,906,745
G
Ddx4
DEAD-box helicase 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDX4 mRNA
CTD
PMID:37748715
NCBI chr 2:45,961,174...46,016,097
Ensembl chr 2:45,961,174...46,015,951
G
Def8
differentially expressed in FDCP 8 homolog
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DEF8 mRNA
CTD
PMID:37748715
NCBI chr19:68,383,293...68,404,133
Ensembl chr19:68,383,349...68,404,125
G
Dnajc5g
DnaJ heat shock protein family (Hsp40) member C5 gamma
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DNAJC5G mRNA
CTD
PMID:37748715
NCBI chr 6:30,980,051...30,984,218
Ensembl chr 6:30,979,869...30,984,115
G
Dnmt1
DNA methyltransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DNMT1 mRNA
CTD
PMID:37748715
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
G
Dusp11
dual specificity phosphatase 11
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP11 mRNA
CTD
PMID:37748715
NCBI chr 4:119,928,533...119,942,643
Ensembl chr 4:119,928,537...119,942,567
G
Dusp16
dual specificity phosphatase 16
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP16 mRNA
CTD
PMID:37748715
NCBI chr 4:169,278,118...169,361,508
Ensembl chr 4:169,278,118...169,361,508
G
Dusp19
dual specificity phosphatase 19
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP19 mRNA
CTD
PMID:37748715
NCBI chr 3:85,945,289...86,081,289
G
Dynll1
dynein light chain LC8-type 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DYNLL1 mRNA
CTD
PMID:37748715
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861
G
Dyrk4
dual specificity tyrosine phosphorylation regulated kinase 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DYRK4 mRNA
CTD
PMID:37748715
NCBI chr 4:161,401,580...161,443,816
Ensembl chr 4:161,401,580...161,443,791
G
E2f8
E2F transcription factor 8
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of E2F8 mRNA
CTD
PMID:37748715
NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EIF4EBP1 mRNA
CTD
PMID:37748715
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
G
Elf1
E74 like ETS transcription factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ELF1 mRNA
CTD
PMID:37748715
NCBI chr15:61,354,026...61,395,762
Ensembl chr15:61,330,877...61,395,758
G
Emc9
ER membrane protein complex subunit 9
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EMC9 mRNA
CTD
PMID:37748715
NCBI chr15:33,041,840...33,046,056
Ensembl chr15:33,041,842...33,046,102
G
Enpep
glutamyl aminopeptidase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ENPEP mRNA
CTD
PMID:37748715
NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:220,456,278...220,526,218
G
Epb41l5
erythrocyte membrane protein band 4.1 like 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EPB41L5 mRNA
CTD
PMID:37748715
NCBI chr13:33,221,705...33,321,400
Ensembl chr13:33,223,589...33,321,133
G
Exosc6
exosome component 6
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of EXOSC6 mRNA
CTD
PMID:37748715
NCBI chr19:55,931,523...55,932,937
Ensembl chr19:55,931,523...55,932,937
G
Fam98a
family with sequence similarity 98, member A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FAM98A mRNA
CTD
PMID:37748715
NCBI chr 6:25,626,108...25,640,767
Ensembl chr 6:25,625,984...25,640,767
G
Fanca
FA complementation group A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FANCA mRNA
CTD
PMID:37748715
NCBI chr19:68,210,562...68,271,080
Ensembl chr19:68,212,643...68,271,019
G
Fbxl12
F-box and leucine-rich repeat protein 12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FBXL12 mRNA
CTD
PMID:37748715
NCBI chr 8:27,453,042...27,459,136
Ensembl chr 8:27,445,823...27,457,772
G
Fbxo5
F-box protein 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FBXO5 mRNA
CTD
PMID:37748715
NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781
G
Fetub
fetuin B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FETUB mRNA
CTD
PMID:37748715
NCBI chr11:91,586,750...91,599,789
Ensembl chr11:91,586,748...91,599,310
G
Fhip2b
FHF complex subunit HOOK interacting protein 2B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FHIP2B mRNA
CTD
PMID:37748715
NCBI chr15:52,066,341...52,084,296
Ensembl chr15:52,066,341...52,083,798
G
Foxk2
forkhead box K2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FOXK2 mRNA
CTD
PMID:37748715
NCBI chr10:107,040,933...107,090,860
Ensembl chr10:107,040,933...107,195,823
G
Fzd4
frizzled class receptor 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FZD4 mRNA
CTD
PMID:37748715
NCBI chr 1:152,692,507...152,701,372
Ensembl chr 1:152,692,507...152,701,372
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GADD45A mRNA
CTD
PMID:37748715
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
G
Gars1
glycyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GARS mRNA
CTD
PMID:37748715
NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876
G
Gas2
growth arrest-specific 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GAS2 mRNA
CTD
PMID:37748715
NCBI chr 1:110,587,952...110,721,572
Ensembl chr 1:110,717,312...110,718,541
G
Gdf15
growth differentiation factor 15
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GDF15 mRNA
CTD
PMID:37748715
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
G
Gid4
GID complex subunit 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GID4 mRNA
CTD
PMID:37748715
NCBI chr10:45,721,055...45,747,132
Ensembl chr10:45,720,759...45,747,323
G
Glb1
galactosidase, beta 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GLB1 mRNA
CTD
PMID:37748715
NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326
G
Gpt2
glutamic--pyruvic transaminase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GPT2 mRNA
CTD
PMID:37748715
NCBI chr19:37,700,023...37,734,551
Ensembl chr19:37,691,901...37,733,917
G
Grb10
growth factor receptor bound protein 10
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of GRB10 mRNA
CTD
PMID:37748715
NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387
G
Grcc10
gene rich cluster, C10 gene
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GRCC10 mRNA
CTD
PMID:37748715
NCBI chr 4:159,237,562...159,239,223
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HADHA mRNA
CTD
PMID:37748715
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HADHB mRNA
CTD
PMID:37748715
NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:31,873,404...31,907,835
G
Hax1
HCLS1 associated protein X-1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HAX1 mRNA
CTD
PMID:37748715
NCBI chr 2:177,731,918...177,735,670
Ensembl chr 2:177,731,921...177,735,390
G
Helz
helicase with zinc finger
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HELZ mRNA
CTD
PMID:37748715
NCBI chr10:92,979,039...93,144,868
Ensembl chr10:92,999,733...93,138,075
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of HERPUD1 mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of HERPUD1 mRNA]
CTD
PMID:37748715
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
G
Herpud2
HERPUD family member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HERPUD2 mRNA
CTD
PMID:37748715
NCBI chr 8:31,849,216...31,894,219
Ensembl chr 8:31,849,216...31,894,219
G
Hexa
hexosaminidase subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HEXA mRNA
CTD
PMID:37748715
NCBI chr 8:68,832,524...68,857,462
Ensembl chr 8:68,809,615...68,859,560
G
Hexim1
HEXIM P-TEFb complex subunit 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HEXIM1 mRNA
CTD
PMID:37748715
NCBI chr10:88,562,889...88,565,001
Ensembl chr10:88,560,519...88,580,000
G
Hmox1
heme oxygenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HMOX1 mRNA
CTD
PMID:37748715
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Iars1
isoleucyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IARS mRNA
CTD
PMID:37748715
NCBI chr17:15,147,357...15,193,716
Ensembl chr17:15,147,357...15,193,652
G
Id2
inhibitor of DNA binding 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ID2 mRNA
CTD
PMID:37748715
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961
G
Inip
INTS3 and NABP interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of INIP mRNA
CTD
PMID:37748715
NCBI chr 5:79,443,317...79,457,552
Ensembl chr 5:79,443,317...79,457,552
G
Irak1bp1
interleukin-1 receptor-associated kinase 1 binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IRAK1BP1 mRNA
CTD
PMID:37748715
NCBI chr 8:92,608,468...92,628,377
Ensembl chr 8:92,611,843...92,628,377
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IRF2BP2 mRNA
CTD
PMID:37748715
NCBI chr19:71,456,689...71,462,368
Ensembl chr19:71,456,689...71,462,368
G
Jam3
junctional adhesion molecule 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of JAM3 mRNA
CTD
PMID:37748715
NCBI chr 8:33,767,606...33,828,451
Ensembl chr 8:33,767,607...33,828,623
G
Jdp2
Jun dimerization protein 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of JDP2 mRNA
CTD
PMID:37748715
NCBI chr 6:110,988,927...111,033,392
Ensembl chr 6:110,992,806...111,033,392
G
Lgals1
galectin 1
multiple interactions decreases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in decreased expression of LGALS1 mRNA]
CTD
PMID:37748715
NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800
G
Lig1
DNA ligase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LIG1 mRNA
CTD
PMID:37748715
NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708
G
Lrfn1
leucine rich repeat and fibronectin type III domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LRFN1 mRNA
CTD
PMID:37748715
NCBI chr 1:92,866,864...92,888,984
Ensembl chr 1:92,874,827...92,888,982
G
Lyrm7
LYR motif containing 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LYRM7 mRNA
CTD
PMID:37748715
NCBI chr10:39,465,019...39,483,973
Ensembl chr10:39,465,036...39,484,240
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MAP2K5 mRNA
CTD
PMID:37748715
NCBI chr 8:72,520,616...72,748,395
Ensembl chr 8:72,520,617...72,747,373
G
Mapre3
microtubule-associated protein, RP/EB family, member 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MAPRE3 mRNA
CTD
PMID:37748715
NCBI chr 6:31,233,736...31,278,626
Ensembl chr 6:31,233,736...31,278,775
G
Mcam
melanoma cell adhesion molecule
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MCAM mRNA
CTD
PMID:37748715
NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406
G
Mdh1
malate dehydrogenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MDH1 mRNA
CTD
PMID:37748715
NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232
G
Midn
midnolin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MIDN mRNA
CTD
PMID:37748715
NCBI chr 7:10,198,761...10,210,563
Ensembl chr 7:10,200,306...10,207,203
G
Mknk1
MAPK interacting serine/threonine kinase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MKNK1 mRNA
CTD
PMID:37748715
NCBI chr 5:134,554,881...134,594,392
Ensembl chr 5:134,554,943...134,594,393
G
Mob4
MOB family member 4, phocein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MOB4 mRNA
CTD
PMID:37748715
NCBI chr 9:64,111,170...64,135,740
Ensembl chr 9:64,111,718...64,135,779
G
Mrps12
mitochondrial ribosomal protein S12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MRPS12 mRNA
CTD
PMID:37748715
NCBI chr 1:93,153,424...93,156,422
Ensembl chr 1:93,153,425...93,159,629
G
Mrps27
mitochondrial ribosomal protein S27
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MRPS27 mRNA
CTD
PMID:37748715
NCBI chr 2:32,474,178...32,542,741
Ensembl chr 2:32,473,965...32,542,738
G
Msmo1
methylsterol monooxygenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MSMO1 mRNA
CTD
PMID:37748715
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445
G
Mt2
metallothionein 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MT2 mRNA
CTD
PMID:37748715
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
G
Mtarc1
mitochondrial amidoxime reducing component 1
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr13:98,854,235...98,894,208
Ensembl chr13:98,871,289...98,894,252
G
Mtarc2
mitochondrial amidoxime reducing component 2
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr13:98,894,347...98,928,754
Ensembl chr13:98,897,108...98,928,781
G
Mtbp
MDM2 binding protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTBP mRNA
CTD
PMID:37748715
NCBI chr 7:88,862,939...88,945,491
Ensembl chr 7:88,862,927...88,945,493
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTHFD1L mRNA
CTD
PMID:37748715
NCBI chr 1:42,849,424...43,038,313
Ensembl chr 1:42,849,374...43,038,309
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of MTHFD2 mRNA]
CTD
PMID:37748715
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350
G
Mtx1
Metaxin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTX1 mRNA
CTD
PMID:37748715
NCBI chr 2:176,913,225...176,919,148
Ensembl chr 2:176,913,225...176,918,824
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MYC mRNA
CTD
PMID:37748715
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
G
Nabp1
nucleic acid binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NABP1 mRNA
CTD
PMID:37748715
NCBI chr 9:57,570,326...57,625,926
Ensembl chr 9:57,618,505...57,626,052
G
Nars1
asparaginyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NARS mRNA
CTD
PMID:37748715
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:60,259,516...60,275,782
G
Ncapd2
non-SMC condensin I complex, subunit D2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCAPD2 mRNA
CTD
PMID:37748715
NCBI chr 4:159,655,051...159,677,938
Ensembl chr 4:159,655,051...159,677,938
G
Ncapg
non-SMC condensin I complex, subunit G
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCAPG mRNA
CTD
PMID:37748715
NCBI chr14:69,616,473...69,645,445
Ensembl chr14:69,616,473...69,645,445
G
Ncor1
nuclear receptor co-repressor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCOR1 mRNA
CTD
PMID:37748715
NCBI chr10:47,498,852...47,641,612
Ensembl chr10:47,498,852...47,640,350
G
Nectin1
nectin cell adhesion molecule 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PVRL1 mRNA
CTD
PMID:37748715
NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:52,998,662...53,086,664
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NSF mRNA
CTD
PMID:37748715
NCBI chr10:89,227,937...89,357,383
Ensembl chr10:89,227,937...89,367,621
G
Nsun3
NOP2/Sun RNA methyltransferase 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NSUN3 mRNA
CTD
PMID:37748715
NCBI chr11:50,960,187...51,062,366
Ensembl chr11:50,960,192...51,045,220
G
Ntaq1
N-terminal glutamine amidase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of WDYHV1 mRNA
CTD
PMID:37748715
NCBI chr 7:91,573,816...91,593,980
Ensembl chr 7:91,553,676...91,626,071
G
Nup85
nucleoporin 85
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NUP85 mRNA
CTD
PMID:37748715
NCBI chr10:101,305,241...101,323,980
Ensembl chr10:101,305,390...101,324,641
G
Nupr1
nuclear protein 1, transcriptional regulator
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of NUPR1 mRNA]
CTD
PMID:37748715
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901
G
Nxf2
nuclear RNA export factor 2
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of NXF2 mRNA
CTD
PMID:37748715
NCBI chr X:102,429,194...102,450,348
Ensembl chr X:102,428,868...102,450,565
G
Ogdh
oxoglutarate dehydrogenase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OGDH mRNA
CTD
PMID:37748715
NCBI chr14:85,363,949...85,431,405
Ensembl chr14:85,364,014...85,432,271
G
Oip5
Opa interacting protein 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OIP5 mRNA
CTD
PMID:37748715
NCBI chr 3:127,047,559...127,057,043
Ensembl chr 3:127,047,559...127,057,043
G
Optn
optineurin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OPTN mRNA
CTD
PMID:37748715
NCBI chr17:78,118,847...78,169,543
Ensembl chr17:78,118,866...78,169,543
G
Osgepl1
O-sialoglycoprotein endopeptidase-like 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OSGEPL1 mRNA
CTD
PMID:37748715
NCBI chr 9:55,707,389...55,725,325
Ensembl chr 9:55,707,392...55,721,346
G
P2rx3
purinergic receptor P2X 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of P2RX3 mRNA
CTD
PMID:37748715
NCBI chr 3:90,487,506...90,531,315
Ensembl chr 3:90,487,506...90,531,794
G
P2rx7
purinergic receptor P2X 7
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of P2RX7 mRNA
CTD
PMID:37748715
NCBI chr12:39,550,531...39,594,984
Ensembl chr12:39,540,567...39,595,193
G
P4ha2
prolyl 4-hydroxylase subunit alpha 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of P4HA2 mRNA
CTD
PMID:37748715
NCBI chr10:38,743,894...38,772,741
Ensembl chr10:38,743,894...38,772,993
G
Pak2
p21 (RAC1) activated kinase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PAK2 mRNA
CTD
PMID:37748715
NCBI chr11:82,212,896...82,273,803
Ensembl chr11:82,212,951...82,273,803
G
Pde3a
phosphodiesterase 3A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDE3A mRNA
CTD
PMID:37748715
NCBI chr 4:175,904,276...176,170,531
Ensembl chr 4:175,904,077...176,169,270
G
Pde4dip
phosphodiesterase 4D interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDE4DIP mRNA
CTD
PMID:37748715
NCBI chr 2:187,982,002...188,178,937
Ensembl chr 2:187,981,878...188,178,869
G
Pds5b
PDS5 cohesin associated factor B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDS5B mRNA
CTD
PMID:37748715
NCBI chr12:5,038,114...5,181,208
Ensembl chr12:5,038,160...5,181,208
G
Pex1
peroxisomal biogenesis factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PEX1 mRNA
CTD
PMID:37748715
NCBI chr 4:31,474,670...31,513,621
Ensembl chr 4:31,470,845...31,513,811
G
Pgam2
phosphoglycerate mutase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PGAM2 mRNA
CTD
PMID:37748715
NCBI chr14:84,895,763...84,897,874
Ensembl chr14:84,895,744...84,897,894
G
Pgp
phosphoglycolate phosphatase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PGP mRNA
CTD
PMID:37748715
NCBI chr10:13,999,782...14,002,408
Ensembl chr10:13,999,331...14,002,408
G
Pmch
pro-melanin-concentrating hormone
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PMCH mRNA
CTD
PMID:37748715
NCBI chr 7:24,399,404...24,400,720
Ensembl chr 7:24,399,404...24,400,720
G
Polr2a
RNA polymerase II subunit A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of POLR2A mRNA
CTD
PMID:37748715
NCBI chr10:54,951,162...54,977,179
Ensembl chr10:54,951,162...54,977,179
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PPP1R15A mRNA
CTD
PMID:37748715
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PPP1R3C mRNA
CTD
PMID:37748715
NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835
G
Psat1
phosphoserine aminotransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PSAT1 mRNA
CTD
PMID:37748715
NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693
G
Psph
phosphoserine phosphatase
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of PSPH mRNA
CTD
PMID:37748715
NCBI chr12:32,527,091...32,541,182
Ensembl chr12:32,519,269...32,541,180
G
Ptk2
protein tyrosine kinase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PTK2 mRNA
CTD
PMID:37748715
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091
G
Rab21
RAB21, member RAS oncogene family
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RAB21 mRNA
CTD
PMID:37748715
NCBI chr 7:52,790,158...52,814,943
Ensembl chr 7:52,790,165...52,814,943
G
Rabggta
Rab geranylgeranyltransferase subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RABGGTA mRNA
CTD
PMID:37748715
NCBI chr15:33,176,268...33,183,320
Ensembl chr15:33,176,099...33,183,271
G
Rad54l
RAD54 like
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RAD54L mRNA
CTD
PMID:37748715
NCBI chr 5:134,812,158...134,841,821
Ensembl chr 5:134,811,532...134,841,425
G
Reep6
receptor accessory protein 6
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of REEP6 mRNA
CTD
PMID:37748715
NCBI chr 7:10,024,601...10,031,507
Ensembl chr 7:10,024,602...10,031,740
G
Rfc2
replication factor C subunit 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RFC2 mRNA
CTD
PMID:37748715
NCBI chr12:27,756,920...27,770,049
Ensembl chr12:27,756,922...27,770,025
G
Rhbdd1
rhomboid domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RHBDD1 mRNA
CTD
PMID:37748715
NCBI chr 9:91,076,786...91,196,719
Ensembl chr 9:91,078,210...91,196,850
G
Rragc
Ras-related GTP binding C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RRAGC mRNA
CTD
PMID:37748715
NCBI chr 5:141,433,014...141,452,546
Ensembl chr 5:141,433,040...141,452,548
G
Rspry1
ring finger and SPRY domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RSPRY1 mRNA
CTD
PMID:37748715
NCBI chr19:10,358,423...10,408,988
Ensembl chr19:10,359,795...10,407,076
G
Samm50
SAMM50 sorting and assembly machinery component
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SAMM50 mRNA
CTD
PMID:37748715
NCBI chr 7:117,197,460...117,221,668
Ensembl chr 7:117,197,381...117,224,581
G
Sars1
seryl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SARS mRNA
CTD
PMID:37748715
NCBI chr 2:198,753,673...198,769,411
Ensembl chr 2:198,753,675...198,769,365
G
Sema6a
semaphorin 6A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SEMA6A mRNA
CTD
PMID:37748715
NCBI chr18:42,237,227...42,358,540
Ensembl chr18:42,237,228...42,358,540
G
Sesn1
sestrin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SESN1 mRNA
CTD
PMID:37748715
NCBI chr20:46,876,918...46,970,010
Ensembl chr20:46,876,895...46,970,010
G
Sesn2
sestrin 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SESN2 mRNA
CTD
PMID:37748715
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
G
Sh3tc1
SH3 domain and tetratricopeptide repeats 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SH3TC1 mRNA
CTD
PMID:37748715
NCBI chr14:79,230,322...79,274,622
Ensembl chr14:79,230,371...79,274,620
G
Shmt2
serine hydroxymethyltransferase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SHMT2 mRNA
CTD
PMID:37748715
NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:65,244,247...65,249,567
G
Ska2
spindle and kinetochore associated complex subunit 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SKA2 mRNA
CTD
PMID:37748715
NCBI chr10:72,418,707...72,436,721
Ensembl chr10:72,418,617...72,436,718
G
Slc1a4
solute carrier family 1 member 4
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of SLC1A4 mRNA
CTD
PMID:37748715
NCBI chr14:98,718,646...98,761,672
Ensembl chr14:98,730,450...98,761,790
G
Slc1a5
solute carrier family 1 member 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC1A5 mRNA
CTD
PMID:37748715
NCBI chr 1:86,584,949...86,599,052
Ensembl chr 1:86,584,949...86,599,054
G
Slc25a31
solute carrier family 25 member 31
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A31 mRNA
CTD
PMID:37748715
NCBI chr 2:125,623,331...125,639,155
Ensembl chr 2:125,623,341...125,654,376
G
Slc25a36
solute carrier family 25 member 36
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A36 mRNA
CTD
PMID:37748715
NCBI chr 8:106,539,355...106,573,240
G
Slc25a4
solute carrier family 25 member 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A4 mRNA
CTD
PMID:37748715
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:52,805,523...52,811,700
G
Slc26a2
solute carrier family 26 member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC26A2 mRNA
CTD
PMID:37748715
NCBI chr18:56,918,662...56,937,032
Ensembl chr18:56,923,337...56,937,012
G
Slc2a1
solute carrier family 2 member 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC2A1 mRNA
CTD
PMID:37748715
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
G
Slc35a4
solute carrier family 35, member A4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC35A4 mRNA
CTD
PMID:37748715
NCBI chr18:28,555,471...28,558,639
Ensembl chr18:28,545,756...28,558,725
G
Slc38a1
solute carrier family 38, member 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A1 mRNA
CTD
PMID:37748715
NCBI chr 7:129,612,414...129,681,727
Ensembl chr 7:129,617,387...129,681,778
G
Slc38a2
solute carrier family 38, member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A2 mRNA
CTD
PMID:37748715
NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:129,730,450...129,742,619
G
Slc38a7
solute carrier family 38, member 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A7 mRNA
CTD
PMID:37748715
NCBI chr19:9,215,336...9,231,592
Ensembl chr19:9,215,383...9,231,589
G
Slc39a4
solute carrier family 39 member 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC39A4 mRNA
CTD
PMID:37748715
NCBI chr 7:110,214,017...110,218,202
Ensembl chr 7:110,214,017...110,218,202
G
Slc3a2
solute carrier family 3 member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC3A2 mRNA
CTD
PMID:37748715
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064
G
Slc44a4
solute carrier family 44, member 4
multiple interactions decreases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in decreased expression of SLC44A4 mRNA]
CTD
PMID:37748715
NCBI chr20:3,907,737...3,923,911
Ensembl chr20:3,907,737...3,923,854
G
Slc6a9
solute carrier family 6 member 9
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC6A9 mRNA
CTD
PMID:37748715
NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:136,659,948...136,694,172
G
Slc7a1
solute carrier family 7 member 1
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of SLC7A1 mRNA]
CTD
PMID:37748715
NCBI chr12:11,664,488...11,740,030
Ensembl chr12:11,664,399...11,740,030
G
Slc7a3
solute carrier family 7 member 3
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of SLC7A3 mRNA
CTD
PMID:37748715
NCBI chr X:70,250,089...70,256,610
Ensembl chr X:70,250,099...70,256,059
G
Slc7a5
solute carrier family 7 member 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC7A5 mRNA
CTD
PMID:37748715
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412
G
Slc7a7
solute carrier family 7 member 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC7A7 mRNA
CTD
PMID:37748715
NCBI chr15:31,792,122...31,852,732
Ensembl chr15:31,792,125...31,835,683
G
Smcr8
SMCR8-C9orf72 complex subunit
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SMCR8 mRNA
CTD
PMID:37748715
NCBI chr10:45,957,146...45,968,388
Ensembl chr10:45,957,104...45,968,389
G
Smim22
small integral membrane protein 22
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SMIM22 mRNA
CTD
PMID:37748715
NCBI chr10:11,079,019...11,080,804
Ensembl chr10:11,078,934...11,080,200
G
Snord1c
small nucleolar RNA, C/D box 1C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SNORD1C mRNA
CTD
PMID:37748715
NCBI chr10:102,404,626...102,404,701
G
Snx4
sorting nexin 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SNX4 mRNA
CTD
PMID:37748715
NCBI chr11:80,965,965...81,023,234
Ensembl chr11:80,965,967...81,028,448
G
Spag7
sperm associated antigen 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SPAG7 mRNA
CTD
PMID:37748715
NCBI chr10:55,875,868...55,882,025
Ensembl chr10:55,875,868...55,882,025
G
Sqle
squalene epoxidase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SQLE mRNA
CTD
PMID:37748715
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050
G
Srxn1
sulfiredoxin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SRXN1 mRNA
CTD
PMID:37748715
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765
G
Stc2
stanniocalcin 2
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of STC2 mRNA]
CTD
PMID:37748715
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447
G
Stil
STIL, centriolar assembly protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of STIL mRNA
CTD
PMID:37748715
NCBI chr 5:133,757,598...133,810,493
Ensembl chr 5:133,760,417...133,810,494
G
Stx7
syntaxin 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of STX7 mRNA
CTD
PMID:37748715
NCBI chr 1:23,016,330...23,056,579
Ensembl chr 1:23,016,336...23,056,465
G
Svil
supervillin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SVIL mRNA
CTD
PMID:37748715
NCBI chr17:57,343,910...57,539,508
Ensembl chr17:57,343,910...57,462,660
G
Sycp1
synaptonemal complex protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SYCP1 mRNA
CTD
PMID:37748715
NCBI chr 2:192,985,164...193,145,234
Ensembl chr 2:192,984,621...193,145,421
G
Tars1
threonyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TARS mRNA
CTD
PMID:37748715
NCBI chr 2:62,095,978...62,114,802
Ensembl chr 2:62,087,763...62,114,802
G
Tas2r108
taste receptor, type 2, member 108
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TAS2R108 mRNA
CTD
PMID:37748715
NCBI chr 4:70,254,367...70,255,281
Ensembl chr 4:70,254,367...70,255,281
G
Tat
tyrosine aminotransferase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TAT mRNA
CTD
PMID:37748715
NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482
G
Tbcc
tubulin folding cofactor C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TBCC mRNA
CTD
PMID:37748715
NCBI chr 9:21,596,472...21,597,660
Ensembl chr 9:21,595,615...21,597,842
G
Tdg
thymine-DNA glycosylase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TDG mRNA
CTD
PMID:37748715
NCBI chr 7:22,965,388...22,990,311
Ensembl chr 7:22,965,388...22,985,100
G
Tec
tec protein tyrosine kinase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TEC mRNA
CTD
PMID:37748715
NCBI chr14:35,706,557...35,815,563
Ensembl chr14:35,691,741...35,815,585
G
Terf1
telomeric repeat binding factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TERF1 mRNA
CTD
PMID:37748715
NCBI chr 5:8,226,345...8,255,614
Ensembl chr 5:8,226,345...8,255,753
G
Thap4
THAP domain containing 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of THAP4 mRNA
CTD
PMID:37748715
NCBI chr 9:101,689,935...101,729,656
Ensembl chr 9:101,689,936...101,729,441
G
Tmppe
transmembrane protein with metallophosphoesterase domain
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TMPPE mRNA
CTD
PMID:37748715
NCBI chr 8:122,963,707...122,971,594
Ensembl chr 8:122,967,106...122,974,054
G
Top2a
DNA topoisomerase II alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TOP2A mRNA
CTD
PMID:37748715
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366
G
Tor1aip1
torsin 1A interacting protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TOR1AIP1 mRNA
CTD
PMID:37748715
NCBI chr13:70,746,941...70,776,382
Ensembl chr13:70,746,941...70,776,123
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRP53INP1 mRNA
CTD
PMID:37748715
NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:29,051,264...29,069,484
G
Tpcn2
two pore segment channel 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TPCN2 mRNA
CTD
PMID:37748715
NCBI chr 1:209,845,827...209,875,561
Ensembl chr 1:209,845,835...209,875,457
G
Trib3
tribbles pseudokinase 3
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of TRIB3 mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of TRIB3 mRNA]
CTD
PMID:37748715
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
G
Trim32
tripartite motif-containing 32
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRIM32 mRNA
CTD
PMID:37748715
NCBI chr 5:84,020,604...84,031,483
Ensembl chr 5:84,014,803...84,042,748
G
Trip12
thyroid hormone receptor interactor 12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRIP12 mRNA
CTD
PMID:37748715
NCBI chr 9:93,364,791...93,491,015
Ensembl chr 9:93,364,791...93,490,159
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRPM6 mRNA
CTD
PMID:37748715
NCBI chr 1:225,559,528...225,747,106
Ensembl chr 1:225,576,872...225,747,108
G
Tubb5
tubulin, beta 5 class I
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TUBB5 mRNA
CTD
PMID:37748715
NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726
G
Tug1
taurine up-regulated 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TUG1 mRNA
CTD
PMID:37748715
NCBI chr14:82,743,501...82,750,534
Ensembl chr14:82,746,113...82,750,534
G
Txnip
thioredoxin interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TXNIP mRNA
CTD
PMID:37748715
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
G
Ugdh
UDP-glucose 6-dehydrogenase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of UGDH mRNA
CTD
PMID:37748715
NCBI chr14:43,202,480...43,226,002
Ensembl chr14:43,202,356...43,226,629
G
Vangl1
VANGL planar cell polarity protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VANGL1 mRNA
CTD
PMID:37748715
NCBI chr 2:192,277,762...192,326,151
Ensembl chr 2:192,280,422...192,326,186
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VEGFA mRNA
CTD
PMID:37748715
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
G
Vtcn1
V-set domain containing T cell activation inhibitor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VTCN1 mRNA
CTD
PMID:37748715
NCBI chr 2:190,942,224...191,010,280
Ensembl chr 2:190,942,224...191,010,280
G
Wars1
tryptophanyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of WARS1 mRNA
CTD
PMID:37748715
NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:133,539,744...133,571,645
G
Yars1
tyrosyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YARS mRNA
CTD
PMID:37748715
NCBI chr 5:146,820,163...146,848,377
Ensembl chr 5:146,819,358...146,848,377
G
Yipf2
Yip1 domain family, member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YIPF2 mRNA
CTD
PMID:37748715
NCBI chr 8:28,417,254...28,421,455
Ensembl chr 8:28,417,278...28,421,455
G
Ypel5
yippee-like 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YPEL5 mRNA
CTD
PMID:37748715
NCBI chr 6:28,408,079...28,423,536
Ensembl chr 6:28,408,080...28,412,385
G
Zfp516
zinc finger protein 516
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ZFP516 mRNA
CTD
PMID:37748715
NCBI chr18:78,561,069...78,661,263
Ensembl chr18:78,573,562...78,674,419
G
Zswim5
zinc finger, SWIM-type containing 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ZSWIM5 mRNA
CTD
PMID:37748715
NCBI chr 5:135,583,356...135,700,390
Ensembl chr 5:135,582,724...135,700,390
G
Abcc2
ATP binding cassette subfamily C member 2
decreases activity
ISO
norgestimate results in decreased activity of ABCC2 protein
CTD
PMID:16049127
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
G
Ar
androgen receptor
multiple interactions affects localization decreases expression
ISO
norgestimate binds to and results in decreased activity of AR protein; norgestimate binds to and results in increased activity of AR protein norgestimate affects the localization of AR protein norgestimate results in decreased expression of AR mRNA
CTD
PMID:17505938 PMID:28478275
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
G
Crp
C-reactive protein
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of CRP protein
CTD
PMID:16982228
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein
CTD
PMID:16291717
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP2C19 protein
CTD
PMID:16291717
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
G
F7
coagulation factor VII
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of F7 protein
CTD
PMID:12618251
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738
G
F8
coagulation factor VIII
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of F8 protein
CTD
PMID:12618251
NCBI chr18:155,237...187,186
Ensembl chr18:155,309...186,683
G
Fga
fibrinogen alpha chain
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein]
CTD
PMID:12618251
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577
G
Fgb
fibrinogen beta chain
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein]
CTD
PMID:12618251
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434
G
Fgg
fibrinogen gamma chain
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein]
CTD
PMID:12618251
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170
G
Pgr
progesterone receptor
multiple interactions
ISO
norgestimate binds to and affects the activity of PGR protein
CTD
PMID:1324557 PMID:15697108
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
G
Plat
plasminogen activator, tissue type
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of PLAT protein; [Ethinyl Estradiol co-treated with norgestimate] results in increased activity of PLAT protein
CTD
PMID:12618251
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
G
Plg
plasminogen
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of PLG protein
CTD
PMID:12618251
NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of PROC protein
CTD
PMID:12618251
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964
G
Pros1
protein S
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of PROS1 protein
CTD
PMID:12618251
NCBI chr11:13,676,310...13,757,858
Ensembl chr11:13,676,769...13,757,852
G
Serpina6
serpin family A member 6
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of SERPINA6 protein
CTD
PMID:16982228
NCBI chr 6:128,544,828...128,555,064
Ensembl chr 6:128,544,831...128,555,139
G
Serpina7
serpin family A member 7
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of SERPINA7 protein
CTD
PMID:16982228
NCBI chr X:107,452,044...107,510,958
Ensembl chr X:107,452,044...107,457,681
G
Serpinc1
serpin family C member 1
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of SERPINC1 protein
CTD
PMID:12618251
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643
G
Shbg
sex hormone binding globulin
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of SHBG protein
CTD
PMID:12586319 PMID:16982228
NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,831,718...54,838,760
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
20874
chemical entity
20872
atom
20872
nonmetal atom
20781
nitrogen atom
19576
nitrogen molecular entity
19576
oxime
408
ketoxime
340
(2E)-2-(hydroxyimino)isohexanoic acid
0
(2R,3R,4R,5S,6Z)-4,5-dihydroxy-6-(hydroxyimino)-2-(hydroxymethyl)piperidin-3-yl 4-O-methyl-alpha-D-maltoside
0
(2R,3R,4R,5S,6Z)-4,5-dihydroxy-6-(hydroxyimino)-2-(hydroxymethyl)piperidin-3-yl alpha-D-maltoside
0
(2Z,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)piperidin-2-one oxime
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(E,E)-bastadin 19
0
(E,Z)-bastadin 19
0
(Z)-D-gluconhydroximo-1,5-lactam
0
(hydroxyimino)(phenyl)acetonitrile
0
1-(4-chlorophenyl)-2-[5-(1-pyrrolidinyl)-2-tetrazolyl]ethanone oxime
0
1-(4-methyl-2-phenyl-5-thiazolyl)ethanone oxime
0
1-[9-ethyl-6-(1-hydroxyiminoethyl)-3-carbazolyl]ethanone oxime
0
11,11-dimethyl-4,8-dimethylenebicyclo[7.2.0]undecan-5-one oxime
0
2,6-diphenyl-3-propyl-4-piperidinone oxime
0
3,3-dimethyl-1-(methylsulfanyl)butan-2-one oxime
0
3,4,5-trihydroxypiperidin-2-one oxime
0
3-(2-allyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime
0
3-(methylsulfanyl)butan-2-one oxime
0
3-Oxopregn-4-ene-20beta-carboxaldehyde dioxime
0
3-allyloxyestra-1,3,5(10),7-tetraene-16,17-dione dioxime
0
4-hydroxyphenylpyruvic acid oxime
0
5-(hydroxyimino)-6-oxo-5,6-dihydronaphthalene-2-sulfonic acid
0
5-methylhexan-2-one oxime
0
6-bromoindirubin-3'-oxime
39
Buccoxime
0
Cyclopentan-1-one oxime
0
Exametazime
0
FIN56
0
FK409
0
GDC-0879
0
Labienoxime
0
N(4)-hydroxycytidine
236
N-\{5-[2-\{4-[2-(dimethylamino)ethoxy]phenyl\}-4-(pyridin-4-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-inden-1-ylidene\}hydroxylamine +
0
Oximoaspergillimide
0
Viridomycin F
0
acetone oxime
0
bastadin 4
0
bastadin 5
0
bastadin 6
0
cefdinir
2
dehydroepiandrosterone 7-O-(carboxymethyl)oxime
0
diacetylmonoxime
9
indan-2-one oxime
0
indirubin-3'-monoxime
49
molnupiravir
0
nocardicin +
0
norgestimate
19
phenylpyruvic acid oxime
0
pyruvic oxime
0
verongamine
0
ximoprofen
0
Path 2
CHEBI ontology
20874
subatomic particle
20883
composite particle
20883
hadron
20872
baryon
20883
nucleon
20872
atomic nucleus
20883
atom
20872
main group element atom
20796
main group molecular entity
20809
p-block molecular entity
20796
pnictogen molecular entity
19695
nitrogen molecular entity
19576
oxime
408
ketoxime
340
(2E)-2-(hydroxyimino)isohexanoic acid
0
(2R,3R,4R,5S,6Z)-4,5-dihydroxy-6-(hydroxyimino)-2-(hydroxymethyl)piperidin-3-yl 4-O-methyl-alpha-D-maltoside
0
(2R,3R,4R,5S,6Z)-4,5-dihydroxy-6-(hydroxyimino)-2-(hydroxymethyl)piperidin-3-yl alpha-D-maltoside
0
(2Z,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)piperidin-2-one oxime
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(E,E)-bastadin 19
0
(E,Z)-bastadin 19
0
(Z)-D-gluconhydroximo-1,5-lactam
0
(hydroxyimino)(phenyl)acetonitrile
0
1-(4-chlorophenyl)-2-[5-(1-pyrrolidinyl)-2-tetrazolyl]ethanone oxime
0
1-(4-methyl-2-phenyl-5-thiazolyl)ethanone oxime
0
1-[9-ethyl-6-(1-hydroxyiminoethyl)-3-carbazolyl]ethanone oxime
0
11,11-dimethyl-4,8-dimethylenebicyclo[7.2.0]undecan-5-one oxime
0
2,6-diphenyl-3-propyl-4-piperidinone oxime
0
3,3-dimethyl-1-(methylsulfanyl)butan-2-one oxime
0
3,4,5-trihydroxypiperidin-2-one oxime
0
3-(2-allyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime
0
3-(methylsulfanyl)butan-2-one oxime
0
3-Oxopregn-4-ene-20beta-carboxaldehyde dioxime
0
3-allyloxyestra-1,3,5(10),7-tetraene-16,17-dione dioxime
0
4-hydroxyphenylpyruvic acid oxime
0
5-(hydroxyimino)-6-oxo-5,6-dihydronaphthalene-2-sulfonic acid
0
5-methylhexan-2-one oxime
0
6-bromoindirubin-3'-oxime
39
Buccoxime
0
Cyclopentan-1-one oxime
0
Exametazime
0
FIN56
0
FK409
0
GDC-0879
0
Labienoxime
0
N(4)-hydroxycytidine
236
N-\{5-[2-\{4-[2-(dimethylamino)ethoxy]phenyl\}-4-(pyridin-4-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-inden-1-ylidene\}hydroxylamine +
0
Oximoaspergillimide
0
Viridomycin F
0
acetone oxime
0
bastadin 4
0
bastadin 5
0
bastadin 6
0
cefdinir
2
dehydroepiandrosterone 7-O-(carboxymethyl)oxime
0
diacetylmonoxime
9
indan-2-one oxime
0
indirubin-3'-monoxime
49
molnupiravir
0
nocardicin +
0
norgestimate
19
phenylpyruvic acid oxime
0
pyruvic oxime
0
verongamine
0
ximoprofen
0